//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
ET Markets
12,129.5073.7
Stock Analysis, IPO, Mutual Funds, Bonds & More

Aurobindo Pharma Ltd.

ET 500

Rank 2019
87
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    16:13 | 29-01-2020
  • BSE
    16:01 | 29-01-2020
507.35

Today's Change

3.25 (0.64%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

1,730,597

Open

505.40

Prev. Close

504.10

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)1.00
  • EPS-TTM (Rs.)28.20
  • BV/share (₹)237.11
  • 52Wk L/H389.35/ 838.00
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News| Speed

Aurobindo Pharma Ltd Stock Price F & O Quotes

Buy Aurobindo Pharma, target Rs 640: Kunal Bothra| Recos
Buy
Buy Aurobindo Pharma, target Rs 625: CK Narayan| Recos
Buy
Buy Aurobindo Pharma, target Rs 618: Jay Thakkar| Recos
Buy
Buy Aurobindo Pharma, target Rs 618: Dr CK Narayan| Recos
Buy
Buy Aurobindo Pharma, target Rs 650: Kunal Bothra| Recos
Buy
Sell Aurobindo Pharma, target Rs 540: Manas Jaiswal| Recos
Sell
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Contact Details Of Registrar And Share Transfer Agent (RTA)| Announcement
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Aurobindo Pharma Ltd.Statement Of Investor Complaints For The Quarter Ended December 2019| Announcement
Aurobindo Pharma Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
Aurobindo Pharma Ltd.Shareholding for the Period Ended December 31, 2019| Announcement
Aurobindo Pharma Ltd.Closure of Trading Window| Announcement
Aurobindo Pharma Ltd.Change In Name Of Registrar & Transfer Agent From Karvy Fintech Private Limited To Kfin Technologies Private Limited| Announcement
Aurobindo Pharma Ltd.Disclosure Of Related Party Transactions For The Half Year Ended 30Th September 2019.| Announcement
Aurobindo Pharma Ltd.Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
Aurobindo Pharma Ltd.Voting Results And Scrutinizers Report Of NCLT Convened Meetings Of The Equity Shareholders And Unsecured Creditors Of A...| Announcement
Aurobindo Pharma Ltd.Outcome Of NCLT Convened Meeting Of The Equity Shareholders Of Aurobindo Pharma Limited (The Company) And Disclosures Un...| Announcement
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Acquisition| Announcement
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Earnings Call Transcript| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
Aurobindo Pharma Ltd.Sub: Completion Of USFDA Inspection At Our Unit IV - Reg.,| Announcement
Aurobindo Pharma Ltd. share price up by 0.64% from its previous close of Rs 504.10. Aurobindo Pharma Ltd. stock last traded price is 507.35
Aurobindo Pharma Ltd. Share Price
Value
Today/Current/Last
507.35
Previous Day
504.10
What's your view on Aurobindo Pharma for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd.
Quarterly Results

Figures in Rs. Cr
Sep 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
5,518.27
3.01
18.24
0.00
8123.35
Other Operating Income
82.20
-6.34
-2.47
0.00
174.16
Operating Profit
1,140.22
-0.54
15.61
-62.92
2640.87
Other Income
20.62
30.67
-21.48
-1.24
200.85
EBITDA
1,160.84
-0.12
14.65
-62.92
2640.87
Interest
40.94
-17.94
15.68
0.00
116.00
Depreciation
243.31
1.02
48.65
0.00
473.28
Tax
224.37
-1.49
27.90
-320.70
266.03
Net Profit
639.86
0.66
4.65
-127.07
1106.80
EPS (₹)
10.92
0.65
4.60
-12.25
66.68

Aurobindo Pharma Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
507.35
0.64
1.89
9.56
7.52
-33.50
-28.90
-16.93
744.85
-0.34
0.87
-3.39
1.46
-13.45
-50.09
-52.09
461.55
-0.68
-2.13
-4.06
-2.43
-8.61
-20.44
-33.82
273.50
0.40
1.60
6.92
9.38
-14.98
-24.54
-17.64
3148.25
-1.28
2.82
8.65
12.34
18.07
5.13
-6.39
312.65
-1.00
0.87
0.76
-5.27
11.71
11.16
0.00
2299.90
-1.06
-2.58
14.02
16.51
21.43
38.56
0.00
1937.50
1.10
-3.17
3.95
7.71
3.28
49.29
70.20
1961.30
0.75
5.72
7.17
11.80
30.34
176.82
121.83
297.45
3.07
1.64
1.73
21.86
-8.22
75.05
335.44
989.15
9.62
14.92
18.45
13.03
27.63
174.23
594.87
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Aurobindo Pharma Ltd Risk Return Comparison

with peersNew

Aurobindo Pharma Ltd
Financial Comparison

with peers
Management Efficiency
Aurobindo Pharma Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
17.02
8.88
-99.01
47.57
Return on Assets (%)
9.06
5.56
-27.48
26.25
Return on capital Employed (%)
10.35
6.02
-130.86
23.01
Fixed Assets Turnover (x)
1.06
-1.92
-193.68
2.79
Profitability and Growth
Gross Profit Margin (%)
16.78
-8.25
-980.00
34.42
Operating Profit Margin(%)
20.20
0.75
-896.19
37.94
Net Profit margin (%)
12.08
1.90
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
1.47
1.62
0.08
9.50
Current Ratio (x)
2.75
2.36
0.21
9.50
Cash ratio (x)
0.34
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.01
0.28
0.00
2.65
Coverage Ratios
Cash flows to long term debt (x)
2.17
3.89
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Aurobindo Pharma Ltd Share Holding as on 31-12-2019

CategoryNo. of sharesPercentage
Promoters285,925,93448.80
ForeignInstitutions125,535,96121.42
NBanksMutualFunds74,862,24212.78
GeneralPublic54,811,0319.35
Others24,469,2484.18
ForeignPromoter18,000,0003.07
FinancialInstitutions2,334,1930.40

MF Ownership Of Aurobindo Pharma Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
HDFC Balanced Advantage Direct-G
Portfolio as on 31-12-2019
Hybrid: Dynamic Asset Allocation
10402928
0.00%
1.07%
475.26
HDFC Equity Direct-G
Portfolio as on 31-12-2019
Equity: Multi Cap
9880295
0.00%
1.9%
451.38
HDFC Hybrid Equity Direct-G
Portfolio as on 31-12-2019
Hybrid: Aggressive Hybrid
7361000
0.00%
1.63%
336.29
HDFC Mid-Cap Opportunities Direct-G
Portfolio as on 31-12-2019
Equity: Mid Cap
4127400
0.00%
0.83%
188.56
L&T Balanced Advantage Direct-G
Portfolio as on 31-12-2019
Hybrid: Dynamic Asset Allocation
1000
-92.31%
0.01%
0.05

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 29525.45 Crore) operating in Pharmaceuticals sector.

Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales) and Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 5518.27 Crore, up 3.01 % from last quarter Sales of Rs 5356.84 Crore and up 18.24 % from last year same quarter Sales of Rs 4667.12 Crore Company has reported net profit after tax of Rs 639.46 Crore in latest quarter.

The company’s top management includes Dr.M Sivakumaran, Dr.(Mrs.)Avnit Bimal Singh, Mr.K Nithyananda Reddy, Mr.K Ragunathan, Mr.M Madan Mohan Reddy, Mr.M Sitarama Murthy, Mr.N Govindarajan, Mr.P Sarath Chandra Reddy, Mr.P V Ramprasad Reddy, Mrs.Savita Mahajan. Company has BSR & Associates LLP as its auditoRs As on 31-12-2019, the company has a total of 585,938,609 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors